Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes
Article full text
The full text of this article can be found here.
Provide enhanced digital features for this article
If you are an author of this publication and would like to provide additional enhanced
digital features for your article then please contact adisrapidplus@springer.com.
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.
Other enhanced features include, but are
not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
• Audio slides
